Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Pharmaceutical Supply – Moxifloxacin Hydrochloride (Antibiotic Medication)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract mandates the manufacture and supply of Moxifloxacin Hydrochloride, an antibiotic medication, in strict compliance with FDA current Good Manufacturing Practices and the Defense Logistics Agency’s medical supply chain protocols. This subcontract is issued under the Department of Defense through the Defense Logistics Agency and is governed by NAICS code 325412, which classifies it within pharmaceutical preparation manufacturing. The product must meet all federal regulatory and logistical standards required for military and defense medical use, ensuring consistent quality, traceability, and timely delivery across the DLA supply network. Production, packaging, labeling, and distribution must align with DLA’s operational requirements, including documentation, quality control, and compliance with federal medical supply chain integrity measures. The contract was posted on June 24, 2026, and is linked to award SPE2DX25D8022 with delivery order SPE2D926F6826, indicating it is an active procurement within the DIBBS system for defense pharmaceutical procurement.

General Info

Manufacture and supply of Moxifloxacin Hydrochloride per FDA and DLA standards for defense medical use.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of SPE2D9-26-F-6826.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

MOXIFLOXACIN HYDROC

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Manufacture and supply of Moxifloxacin Hydrochloride in compliance with FDA cGMP and DLA medical supply chain requirements.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

NAICS: 335910
New
DIBBS
BATTERY, STORAGE
Solicitation # SPE7L7-26-Q-2418
Solicitation SPE7L7-26-Q-2418 is a firm-fixed-price request for quotations issued by the Defense Logistics Agency Land and Maritime for the procurement of sealed lead acid storage batteries, identified by NSN 6140-01-624-9682. The requirement consists of two line items totaling eight units, with two units for item 0001 and six units for item 0002. Approved sources include EnerSys Delaware Inc. (part numbers ODS-AGM6M or PC2250) and Stored Energy Products, Inc. (part number PC2250). These items are designated as critical application items and are restricted source items requiring engineering source approval by the government design control activity. The batteries are classified as Type I (Code H) with a non-extendable shelf life of 12 months. Delivery is required within 60 days after receipt of the order, with shipping terms set as FOB Destination. Packaging and marking must comply with MIL-STD-2073-1E, MIL-STD-129, and DLA packaging requirements RP001, while hazardous materials must be handled according to IP025 and FAR 52.223-3. Quality assurance will be managed through destination inspection and acceptance using sampling methods such as MIL-STD-1916 or ASQ H1331. Award will be based on cost alone for quotes that conform to the solicitation requirements. Quotations must be submitted by September 21, 2026, and payment will be processed electronically via the Wide Area WorkFlow system.
Battery Manufacturing

POSTED

about 23 hours ago

DEADLINE

in 9 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS